Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.

Diabetes, obesity & metabolism·2023
Same author

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.

Diabetes, obesity & metabolism·2022
Same author

HLA Genotypes and Type 1 Diabetes and Its Relationship to Reported Race/Skin Color in Their Relatives: A Brazilian Multicenter Study.

Genes·2022
Same author

Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.

Diabetes, obesity & metabolism·2022
Same author

Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.

Frontiers in endocrinology·2022
Same author

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER.

BMC endocrine disorders·2022

Related Experiment Video

Updated: Jun 19, 2026

Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique
13:19

Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique

Published on: December 16, 2017

Post-transplant diabetes mellitus.

Marília B Gomes1, Roberta A Cobas

  • 1Diabetes and Metabology Unit from Pedro Ernesto University Hospital, Medical Science School, State University of Rio de Janeiro (UERJ. mariliabgomes@uol.com.br.

Diabetology & Metabolic Syndrome
|October 15, 2009
PubMed
Summary

Post-transplant diabetes mellitus (PTDM) is a serious complication after organ transplants, with varied incidence. Identifying risk factors like immunosuppression therapy is crucial for patient outcomes.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Endocrinology

Background:

  • Diabetes Mellitus is a growing global health concern.
  • Post-transplant diabetes mellitus (PTDM) is a significant complication following solid organ transplantation.
  • PTDM incidence varies widely (2-53%) and impacts patient survival and healthcare costs.

Purpose of the Study:

  • To highlight the risk factors associated with PTDM development.
  • To emphasize the importance of early PTDM diagnosis and management.
  • To underscore the impact of PTDM on transplant success and patient longevity.

Main Methods:

  • Review of existing literature on PTDM risk factors.
  • Analysis of factors contributing to PTDM incidence post-transplantation.

More Related Videos

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

Related Experiment Videos

Last Updated: Jun 19, 2026

Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique
13:19

Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique

Published on: December 16, 2017

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

  • Identification of key immunosuppressive agents linked to PTDM.
  • Main Results:

    • Age, ethnicity, viral infections (HCV, CMV), obesity, and specific immunosuppression regimens are identified risk factors for PTDM.
    • High-dose tacrolimus and corticosteroids significantly increase PTDM risk.
    • PTDM is linked to increased risks of infections and cardiovascular disease.

    Conclusions:

    • Early identification of PTDM risk factors and prompt diagnosis are vital for managing this complication.
    • Effective PTDM management strategies are essential for improving patient survival and graft durability.
    • Addressing PTDM is critical for reducing long-term healthcare burdens associated with organ transplantation.